N@N

BUD, EDV, MGLN, ANGO, AG, AIZ Are Seasonally Ripe To Go Up In the Next Five Weeks

March 16, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of Anheuser Busch Inbev SA (NYSE:BUD), Vanguard Extended Duration ETF (NYSE:EDV), Magellan Health Inc. (NASDAQ:MGLN), AngioDynamics Inc. (NASDAQ:ANGO), First Majestic Silver Corp. (NYSE:AG), Assurant Inc. (NYSE:AIZ) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Up:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  BUD     Anheuser Busch Inbev SA          1.52%            100.00% (7 of 7)     Wednesday, March 22nd 2017
  EDV     Vanguard Extended Duration ETF   1.17%            88.89% (8 of 9)      Wednesday, March 22nd 2017
  MGLN    Magellan Health Inc.             2.28%            84.62% (11 of 13)    Wednesday, March 22nd 2017
  ANGO    AngioDynamics Inc.               2.61%            100.00% (12 of 12)   Friday, March 17th 2017
  AG      First Majestic Silver Corp.      3.99%            66.67% (4 of 6)      Friday, March 17th 2017
  AIZ     Assurant Inc.                    6.76%            84.62% (11 of 13)    Friday, April 28th 2017

Anheuser Busch Inbev SA (NYSE:BUD) - Anheuser-Busch InBev SA/NV, a brewing company, engages in the production, distribution, and sale of beer, alcoholic beverages, and soft drinks worldwide. It offers a portfolio of approximately 500 beer brands, including Budweiser, Corona, and Stella Artois; Beck s, Castle, Castle Lite, Hoegaarden, and Leffe; and Aguila, Antarctica, Bud Light, Brahma, Cass, Chernigivske, Cristal, Harbin, Jupiler, Klinskoye, Michelob Ultra, Modelo Especial, Quilmes, Victoria, Sedrin, Sibirskaya Korona, and Skol brands. The company was founded in 1366 and is headquartered in Leuven, Belgium..

Vanguard Extended Duration ETF (NYSE:EDV) - CON EDISON 7.5 PI.

Magellan Health Inc. (NASDAQ:MGLN) - Magellan Health, Inc. engages in the healthcare management business in the United States. The company s Healthcare segment engages in the management of behavioral healthcare services and employee assistance program services; management of other specialty areas, including diagnostic imaging and musculoskeletal management; and the integrated management of physical, behavioral, and pharmaceutical healthcare for special populations comprising individuals with serious mental illness, dual eligibles, long-term services and supports, and other populations with unique and often complex healthcare needs. This segment provides its healthcare services through its comprehensive network of medical and behavioral health professionals, clinics, hospitals, and ancillary service providers. Its Pharmacy Management segment offers products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. This segment offers pharmacy benefit management services, pharmacy benefit administration for state Medicaid and other government sponsored programs; pharmaceutical dispensing operations; clinical and formulary management programs; medical pharmacy management programs; and programs for the management of specialty drugs that treat complex conditions. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, and third party administrators. Magellan Health, Inc. was founded in 1969 and is based in Scottsdale, Arizona..

AngioDynamics Inc. (NASDAQ:ANGO) - AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for vascular access, surgery, peripheral vascular disease, and oncology in the United States and internationally. The company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. In addition, the company provides thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. Further, it offers peripherally inserted central catheters; ports that are implantable devices for the central venous administration; and dialysis products. Additionally, the company provides microwave ablation products; radiofrequency ablation products for ablating solid cancerous or benign tumors; and NanoKnife ablation systems for the surgical ablation of soft tissues. AngioDynamics, Inc. sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York..

First Majestic Silver Corp. (NYSE:AG) - First Majestic Silver Corp. engages in the acquisition, exploration, development, and production of mineral properties with a focus on silver projects in Mexico. The company owns and operates six silver producing mines, including the Santa Elena Silver/Gold Mine, La Encantada Silver Mine, La Parrilla Silver Mine, Del Toro Silver Mine, San Martin Silver Mine, and the La Guitarra Silver Mine. It also holds interests in the Plomosas Silver Project situated in Sinaloa State; La Luz Silver Project located in San Luis Potosi State; Jalisco group of Properties situated in various mining districts in Jalisco, Mexico; Ermitano Silver Project; and La Joya Silver Project in the city of Durango, Mexico. In addition, First Majestic Silver Corp. engages in the retail of coins and bullions in Canada; and sells silver metal in Europe. The company was formerly known as First Majestic Resource Corp. and changed its name to First Majestic Silver Corp. in November 2006. First Majestic Silver Corp. was founded in 1979 and is headquartered in Vancouver, Canada..

Assurant Inc. (NYSE:AIZ) - Assurant, Inc., through its subsidiaries, provides risk management solutions for housing and lifestyle markets worldwide. The company s Global Housing segment provides lender-placed, homeowners, voluntary manufactured housings, and floods insurance services; renters insurance and related products; and mortgage solutions comprising property inspection and preservation services, valuation and title services, and other property risk management services. Its Global Lifestyle segment offers mobile device protection products and related services, and extended service contracts for consumer electronics and appliances; vehicle protection services; and credit and other insurance services. The company s Global Preneed segment provides pre-funded funeral insurance and annuity products. The company was formerly known as Fortis, Inc. and changed its name to Assurant, Inc. in February 2004. Assurant, Inc. was founded in 1969 and is headquartered in New York, New York..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net